NUTRIFARMA
La probabilité de faillite calculée de NUTRIFARMA sur 12 mois est de 0,4% (très faible). L'entreprise est active depuis 1996 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.
| Active | 30 ans |
| Sites | 1 |
| Publications | 1 |
Estimation statistique fondée sur des sources publiques, pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
| Exercice | Type | Dépôt | Référence |
|---|---|---|---|
| 31-12-2025 | verkort | 11-06-2026 | 2026-00159377 |
| 31-12-2024 | verkort | 14-07-2025 | 2025-00271856 |
| 31-12-2023 | verkort | 10-07-2024 | 2024-00236127 |
| 31-12-2022 | verkort | 31-07-2023 | 2023-00308005 |
| 31-12-2021 | verkort | 12-07-2022 | 2022-20175461 |
| 31-12-2020 | verkort | 26-07-2021 | 2021-40500067 |
| 31-12-2019 | micro | 08-10-2020 | 2020-60700057 |
| 31-12-2018 | verkort | 30-07-2019 | 2019-42000117 |
| 31-12-2017 | verkort | 26-07-2018 | 2018-39400059 |
| 31-12-2016 | micro | 25-08-2017 | 2017-52900485 |
| NACE primaire | Commerce de gros(46389) |
| Forme juridique | SA(014) |
| Date de constitution | 04-06-1996 |
| Status | Actif |
| Code postal | 2220 |
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active, pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 12014A0599/00C002 | Flandre | 441 m² | 1 · 139 m² | 8,4 m · 2 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise, publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
16-02-2022 Augmentation de capital de 205.296 € à 835.296 €
- €630.000 → €835.296
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 835296.0,
"delta_eur": 205296.0,
"before_eur": 630000.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "PICARD Johan Juul Jozef",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 611,
"contribution_amount_eur": 339175.5
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "MYLLE Katrien Marguerite Edmonde",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 611,
"contribution_amount_eur": 339175.5
}
],
"share_emission": {
"agio_eur": 473055.0,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1222,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 205296.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "DEMACOM",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "MYLLON CONSULT",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "JP ENTERPRISES",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "CORPOROS",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Frank Muller",
"firm_city": null,
"firm_name": null,
"office_city": "Stekene",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2022-02-16",
"filing_date": "2022-02-14",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-01-31",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0458.087.349",
"name_full": "NUTRIFARMA",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 4972,
"class_name": "Gewone Aandelen",
"capital_share_eur": 835296.0,
"voting_rights_per_share": 1.0
}
]
}Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.
| Dénomination légaleNL | NUTRIFARMA |